课题基金 / 基金详情

Instrumented i-GRASP for the assessment and treatment of upper extremity function after neurological injury

Instrumented i-GRASP for the assessment and treatment of upper extremity function after neurological injury
仪器化 i-GRASP 用于神经损伤后上肢功能的评估和治疗
批准号:
549589-2020
负责人:
Eng, JaniceJJ
金额:
$6.64万
依托单位国家:
加拿大
项目类别:
Collaborative Health Research Projects
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-01-01 至 2023-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Neurological conditions such as stroke and traumatic brain injury can seriously impair onesability to use their arm and hands for essential activities of daily living. We have previouslydeveloped the Graded Repetitive Arm Supplementary Program (GRASP) which has beenshown in a multi-site randomized controlled trial to improve upper extremity function afterstroke through hundreds of repetitions of the arm, hand and fingers, as well as strengtheningexercises. It is utilized in over 3000 sites and is part of the Canadian Stroke Best PracticeRecommendations. Under ideal supervisory conditions, the program is effective, butadherence is problematic as it is difficult to keep track of the many repetitions, can bechallenging to know how to continually make the tasks harder, and lacks feedback to motivateindividuals to do the exercise. I-GRASP will solve these issues by developing an instrumentedplatform derived from the evidence-based GRASP program where patients will be able to 1)measure their own upper extremity function, 2) improve their function through progressiveexercises and 3) and receive feedback to help motivate their progress. Our team is acollaboration between engineer and health care researchers and our partners include awearable sensor company, a public sector rehabilitation hospital, and a private rehabilitationclinic to ensure the relevance of our product. The proposed technology to measure, motivateand enhance hand function will improve the lives of individuals with stroke and will beapplicable to other populations with hand problems. The project will also advancetechnologies related to smart materials and wearable sensors. Lastly, the research has greatpotential for commercialization by the industry partner Texavie and to potentially open newmarkets for rehabilitation technology that can be accessed by health providers and strokesurvivors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
新型莲心碱简化物靶向GRASP55抑制自噬逆转胃癌多药耐药的机制研究
高尔基体结构蛋白GRASP55参与膜融合的功能鉴定和调控机制研究
  • 批准号:
    32070693
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    张晓妍
  • 依托单位:
高尔基体堆叠蛋白GRASP55 去糖基化介导Aβ促进自噬溶酶体形成
  • 批准号:
    2019JJ50495
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2019
  • 负责人:
    赵剑锋
  • 依托单位:
人源高尔基体蛋白GRASP55的结构与功能研究